Cramer’s lightning round: There are better drug stocks to own than GlaxoSmithKline

Cramer’s lightning round: There are better drug stocks to own than GlaxoSmithKline

GlaxoSmithKline PLC: “We don’t care where a stock’s been, we care where it’s going, but it is at $37. It’s got a 5 percent yield. [CEO] Emma Walmsley is supposed to be doing a good job. I have not seen what I’d like to see from that company. As far as I’m concerned, there are much better drug stocks to own than Glaxo.” SiteOne Landscape Supply Inc.: “No. You don’t want to be there because people don’t like housing right now and it’s going to be affiliated with the housing…

Read More